These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4267603)

  • 21. [Mood, behavior and drugs].
    Monti A
    Minerva Med; 1971 May; 62(40 Suppl):33-4. PubMed ID: 5555948
    [No Abstract]   [Full Text] [Related]  

  • 22. 5-Hydroxytryptamine and pain modulation in man: a clinical pharmacological approach with tryptophan and parachlorophenylalanine.
    Sicuteri F; Anselmi B; Del Bene E; Galli P
    Acta Vitaminol Enzymol; 1975; 29(1-6):66-8. PubMed ID: 146417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversal learning enhanced by lysergic acid diethylamide (LSD): concomitant rise in brain 5-hydroxytryptamine levels.
    King AR; Martin IL; Melville KA
    Br J Pharmacol; 1974 Nov; 52(3):419-26. PubMed ID: 4458849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behavioral evidence for the stimulation of CNS serotonin receptors by high doses of LSD.
    Trulson ME; Ross CA; Jacobs BL
    Psychopharmacol Commun; 1976; 2(2):149-64. PubMed ID: 136010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical effects of para-chlorophenylalanine in Parkinson's disease.
    Van Woert MH; Ambani LM; Levine RJ
    Dis Nerv Syst; 1972 Dec; 33(12):777-80. PubMed ID: 4272666
    [No Abstract]   [Full Text] [Related]  

  • 26. Methods for assessing the interaction of agents with 5-hydroxytryptamine neurons and receptors in the brain.
    Jalfre M; Ruch-Monachon MA; Haefely W
    Adv Biochem Psychopharmacol; 1974; 10():121-34. PubMed ID: 4276951
    [No Abstract]   [Full Text] [Related]  

  • 27. Uptake of 5-hydroxytryptamine by Schistosoma mansoni.
    Bennett JL; Bueding E
    Mol Pharmacol; 1973 May; 9(3):311-9. PubMed ID: 4267956
    [No Abstract]   [Full Text] [Related]  

  • 28. Possible involvement of brain serotonin in apomorphine-induced hypothermia.
    Grabowska M; Michaluk J; Antkiewicz L
    Eur J Pharmacol; 1973 Jul; 23(1):82-9. PubMed ID: 4270157
    [No Abstract]   [Full Text] [Related]  

  • 29. Chemical-feedback regulation of serotonin-containing neurons in brain.
    Aghajanian GK
    Ann N Y Acad Sci; 1972 Aug; 193():86-94. PubMed ID: 4262796
    [No Abstract]   [Full Text] [Related]  

  • 30. Eosinophilia myalgia syndrome. The role of contaminants, the role of serotonergic metabolism set up.
    Nicolodi M; Sicuteri F
    Adv Exp Med Biol; 1996; 398():351-7. PubMed ID: 8906288
    [No Abstract]   [Full Text] [Related]  

  • 31. Influence on 5-[3H]hydroxytryptamine binding site development in chick embryo by serotonergic compounds.
    Soblosky JS; Jeng I
    J Neurochem; 1985 Feb; 44(2):544-51. PubMed ID: 2578180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of brain serotonin in the stimulant action of amphetamine and of cholinolytics.
    Lapin IP; Oxenkrug GF; Azbekyan SG
    Arch Int Pharmacodyn Ther; 1972 Jun; 197(2):350-61. PubMed ID: 4260601
    [No Abstract]   [Full Text] [Related]  

  • 33. Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role?
    Whelan A; Johnson MI
    Pain Manag; 2018 May; 8(3):217-229. PubMed ID: 29722608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of serotonin depletion on the discriminability of LSD.
    White FJ; Simmons MA; West KB; Holohean AM; Appel JB
    Pharmacol Biochem Behav; 1980 Oct; 13(4):569-74. PubMed ID: 6449014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of drugs on the firing of serotonin-containing neurons in brain.
    Aghajanian GK
    Fed Proc; 1972; 31(1):91-6. PubMed ID: 4333252
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical and rheographic considerations on a new antiserotonin derivative (UML-491) with preventive action in hemicrania].
    REBUCCI GG; COCCAGNA G
    Riv Neurol; 1962; 32():574-85. PubMed ID: 13973457
    [No Abstract]   [Full Text] [Related]  

  • 37. [Various psychodysleptic substances].
    Bernik V
    Rev Paul Med; 1972 Aug; 80(2):115-7. PubMed ID: 4671580
    [No Abstract]   [Full Text] [Related]  

  • 38. Mescaline, lysergic acid diethylamide and psilocybin comparison of clinical syndromes, effects on color perception and biochemical measures.
    HOLLISTER LE; HARTMAN AM
    Compr Psychiatry; 1962 Aug; 3():235-42. PubMed ID: 13908449
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of lysergic acid diethylamide, 5-hydroxytryptamine, and related compounds on the liver fluke, Fasciola hepatica.
    MANSOUR TE
    Br J Pharmacol Chemother; 1957 Dec; 12(4):406-9. PubMed ID: 13489165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. III: The mechanistic basis for supersensitivity to the LSD stimulus following serotonin depletion.
    Fiorella D; Helsley S; Lorrain DS; Rabin RA; Winter JC
    Psychopharmacology (Berl); 1995 Oct; 121(3):364-72. PubMed ID: 8584619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.